Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0028754 (obesity)
 124,988 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The aim of the study was to evaluate the effect of clinical factors on variation in the health-related quality of life (HRQoL) of patients with arterial essential hypertension. An open questionnaire study was performed among 1539 subjects (775 men and 764 women) aged from 18 to 88 years (mean age 51.7 +/- 14.6 years) with arterial hypertension diagnosed at least 3 months earlier. The patients had been treated (86.2%) or started treatment (17.4%) in municipal outpatient units and in the Antihypertensive Outpatient Center of the I Cardiac Department. The following data were analyzed: systolic and diastolic blood pressure, heart rate, body mass, target organ complications and number of hypotensive drugs. All patients completed a standardized Psychological General Well-Being questionnaire (PGWB) to evaluate the general quality of life and its six dimensions: anxiety, depressive mood, well-being, self-control, general health and vitality. Irrespective of the patients' gender the general quality of life was poorer in those patients in whom systolic blood pressure exceeded 140 mmHg. The highest general quality of life was observed in patients with diastolic blood pressure between 74 and 90 mmHg. In patients with BMI > 30 kg/m2 the HRQoL was significantly lower. In obese patients as compared with normal and overweight patients the following scales of the PGWB were significantly lower: general health and vitality, whereas the score of depressive mood was higher (p < 0.05). Furthermore obese patients had significantly higher SBP and DBP than slim subjects. Both in men and women with arterial hypertension there was a negative relationship between the quality of life and the presence of target organ complications and the number of drugs used. Among the patients treated with 4 and more hypotensive drugs the proportion of subjects with controlled blood pressure was lower as compared with those receiving 1, 2 or 3 drugs. Multiple regression analysis showed that the clinical factors independently affecting the general quality of life in patients with arterial hypertension were systolic and diastolic blood pressure, obesity, target organ complications and the number of hypotensive drugs used. These factors accounted for 37.1% of variance in the general quality of life.
 ...
PMID:[Quality of life in patients with essential arterial hypertension. Part II: The effect of clinical factors]. 1293 56

Type 2 diabetes and obesity co-occur in high prevalence among African-American women. The positive value placed on large body size has both historic and contemporary biosocial relevance. The maintenance of weight at medically recommended levels is a cornerstone of both prevention and treatment of Type 2 diabetes. This study of overweight, elderly, rural African-American women with Type 2 diabetes found they generally preferred smaller body sizes compared to previous studies. Normal to slim body images as presented in a photographic array were selected as being more attractive, less likely to have diabetes and hypertension, healthier and to be more medically compliant than obese, grossly obese or very thin images. Body image is a psychosocial variable that should be included in weight control initiatives.
 ...
PMID:Body image among older, rural, African-American women with type 2 diabetes. 1297 35

Peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC1alpha) is an accessory protein which can potentiate the transcriptional activation function of many nuclear hormone receptors. Its tissue distribution and physiological studies suggest that its principal in vivo roles are to promote cold-induced thermogenesis, mitochondrial biogenesis, hepatic gluconeogenesis, and fatty acid beta-oxidation. It is expressed in the white adipose tissue of both humans and rodents, and in rodents it has been suggested to mediate in part the leptin-induced conversion of white adipocytes from fat storing to fat oxidising cells. In this study, quantitative real-time PCR has been used in human tissue to demonstrate that (1) PGC1alpha mRNA levels in subcutaneous fat are three-fold lower in morbidly obese than in slim subjects; (2) there are no differences in PGC1alpha mRNA between omental and subcutaneous mature adipocytes; (3) there is a robust induction of PGC1alpha expression during subcutaneous human preadipocyte differentiation ex vivo. Whether low PGC1alpha expression is a prelude to the development of obesity, or a consequence of that obesity, attempts to upregulate endogenous white adipose tissue expression may prove a valuable new avenue to explore in obesity therapy.
 ...
PMID:Expression of the thermogenic nuclear hormone receptor coactivator PGC-1alpha is reduced in the adipose tissue of morbidly obese subjects. 1455 31

Breast cancer patients who are obese have a higher risk of lymph node metastases and a poorer prognosis than those who are slim. It has been claimed that estrogens derived from fat are important for these associations. If estrogens are important, these relationships must be stronger in the hormone receptor-positive than in the hormone receptor-negative groups. Body mass index (BMI) was used as a measure of obesity. The second, third, and fourth quintiles of BMI were treated as one group and termed 'medium'. Patients in the fifth quintile were termed 'obese' and those in the first quintile 'slim'. The number of women with unilateral disease treated with modified radical mastectomy and included in the study was 1211. Of all patients included, obese patients had a 1.53 higher risk of lymph node metastases compared to slim patients (p=0.02). In the PgR-negative group, obesity gave a 3.08 times higher risk of lymph node metastases (p=0.03). The risk of dying of breast cancer tended to be higher in obese than in slim patients when all patients in the study were compared (relative risk=1.38, p=0.06). BMI did not show a statistically significant relationship with prognosis if only hormone receptor status was considered. However, if lymph node status and hormone receptor status were taken together, the association was strong and reversed in the lymph node-positive group with ER-negative tumours. The adjusted relative risk was 0.33, showing that slim patients had a 3.03 (1.0/0.33) times higher risk of dying of breast cancer compared to obese patients (p=0.002). These results indicate that non-hormonal mechanisms could be important.
 ...
PMID:The associations of obesity, lymph node status and prognosis in breast cancer patients: dependence on estrogen and progesterone receptor status. 1551 Dec 72

Liver fibrosis is the consequence of chronic or repeated liver injury caused by hepatotoxic agents like alcohol and viruses, as well as immune and congenital metabolic disorders. Nonalcoholic fatty liver disease (NAFLD), caused by obesity and abnormal lipid metabolism, may be the latest known cause of liver fibrosis and cirrhosis. Furthermore, NAFLD with obesity can provide a terrain in which alcoholic and viral liver diseases, such as chronic hepatitis C, are prone to cause liver cirrhosis. Insulin, insulin-like growth factor (IGF)-1, peroxisome proliferator-activated receptors (PPARs), leptin, adiponectin, and preadipocyte factor-1/delta-like1 (Pref-1/dlk1) are hormones, growth factors, nuclear receptors, and cytokines that are actively involved in lipid metabolism. They share common target cells important in liver fibrosis, i.e., hepatic stellate cells (HSCs). Activation of HSCs is known to initiate and perpetuate liver fibrosis. Insulin and IGF-1 stimulate HSC activation and collagen production in vitro. However, IGF-1 alleviates liver fibrosis in vivo. Ligands of PPARy inhibit HSC activation and collagen synthesis in vivo and in vitro, and are helpful in decreasing liver fibrosis. But ligands of PPARbeta enhance proliferation of HSCs. Leptin is profibrogenic, and liver fibrosis is decreased in leptin- or leptin receptor-deficient mice. Adiponectin is, on the contrary, anti-fibrogenic. Extensive liver fibrosis may develop in adiponectin-knockout mice and is alleviated by administration of recombinant adiponectin. Pref-1/dlkl is implicated in fibrogenesis of the liver through its modulation of HSCs. The use of such biologically active molecules in lipid metabolism as ligands of PPARgamma and adiponectin might not help slim down a patient on the whole, but can potentially be used to halt the progression of liver fibrosis. Weight reduction, a strategy for controlling obesity and metabolic syndromes, may also be a tool for decreasing NAFLD and alleviating liver cirrhosis.
 ...
PMID:An adipocentric view of liver fibrosis and cirrhosis. 1575 75

Obesity is a known risk factor of cholecystolithiasis. The potential causes of increased incidence of cholecystolithiasis in people with obesity (overweight) and in those with normal body mass are considered. The study involved 100 patients with diagnosed cholecystolithiasis hospitalized in one of the randomly selected hospitals in Bialystok and its vicinity. The questionnaire technique was used to evaluate risk factors of cholecystolithiasis. It was found that women, irrespective of body mass, were 2.7 times more often hospitalized due to this ailment than men. Of the patients examined, 71% had overweight or obesity. Women with normal body mass suffered from cholecystolithiasis at the younger age than the obese or overweight ones. The comparison of risk factors of cholecystolithiasis between the obese (overweight) patients and those with normal body mass revealed a significantly more frequent familial incidence of type 2 diabetes and cholecystolithiasis. Patients with cholecystolithiasis, irrespective of body mass, were characterized by low intake of dark bread and wholemeal products, raw fruit and vegetables, and pulses. Obese women with cholecystolithiasis significantly more frequently consumed milk and yoghurt, meat and its products, lard, bacon and sweets than women with normal body mass. Obese men (with overweight) significantly more frequently consumed high-fat foods than the slim ones.
 ...
PMID:[Risk factors for cholecystolithiasis in obesity and at normal weight]. 1608 Apr 46

In recent decades a new ideal of beauty has evolved characterised by slim women and muscular men; obesity, which in past centuries was considered healthy and attractive, is now "out of fashion". The news media devote ample space, especially during spring and summer, to diet and fitness programs, and many diets and devices, without any scientific evidence, are presented as miracle cures. The business of diets and "natural" products generates intensive campaigns developed to promote foods, nutritional programs, and specific tools for losing weight as rapidly and effortlessly as possible. In this context, general practitioners and specialists have a fundamental role to play in correcting the often distorted messages that the general public receives, through educational programs designed to promote a correct understanding of the cardiovascular risks of obesity and healty methods and treatments for losing weight and safely achieving real health objectives.
 ...
PMID:[News and advertising on foods, diet and obesity]. 1612 66

The pediatric obesity has become a real problem for the public health. One estimates that about 16% of the Belgian pediatric population and up to 33% of the Americans are concerned by this problematic. 70% of the teenagers will remain obese once adult if no treatment is proposed during the childhood. Because of that evolution, some journalists wrote: "that the old continent would be able to catch up with the new world in the next ten years". The malnutrition is not however the only factor at the origin of the obesity. The sedentary lifestyle (lack of exercise, TV, Internet, video games) the domestic organization, the "various emotional stress "are to be blamed. It is without taking into consideration the paradox of our consumption society that while extolling the cult of the slim, young and dynamic body, etc., pushes us to consume more, encouraging in some social and cultural surroundings to go for the immediate pleasure to the detriment of the knowledge - understanding - of our own body. Which places the obese child in an existential paradox. If on top of it there is a domestic predisposition to the plumpness, the kilograms in excess are threatening the unsecured child and new sufferings stand out on the horizon : relational unrests, isolation, social dismissal, reduction of the esteem of selfesteem as well as lack of confidence, less freedom, depression, etc. Not only are they victims of mockeries, aggressiveness and exclusion, the children put their health in danger. On those children we can notice an increase of the impact of cardiovascular pathologies, diabetes, cancers of the intestines, etc. In "Clairs Vallons" we put the hypothesis that the children and the teenagers who come here in custody could suffer from a lack of presence as well as people listening to them and that therefore to would search for comfort in eating. We consider that all interventions based solely on the interdiction of the symptom have no result, causes more suffering and a displacement of the symptom. The therapeutic work to the Dietary Residency of "Clairs Vallons" consists therefore in a global approach of the child within a multidisciplinary team (pediatrician, dietitian, psychologist, physiotherapist, social assistant, orthofenist, educator and teacher) all united around the concept "to eat happy".
 ...
PMID:[Multidisciplinary approach of the obese child to the dietary residency of "Clairs Vallons"]. 1624 Aug 63

Differentiation of the various forms of diabetes is necessary for therapeutic reasons. Typical signs of type 2 diabetes are age over 40, obesity, and other markers for metabolic syndrome, a positive famitory, gradual development of the classical symptoms, and no evidence of ketosis. It is important to distinguish this from LADA (latent autoimmune diabetes of adulthood), a form of type 1 diabetes mellitus. To establish this differential diagnosis antibody testing is employed. Antibody tests in patients with newly manifest diabetes make good sense when the clinical diagnosis is not unequivocal, that is, to distinguish it from type 2 diabetes, MODY diabetes, hereditary and secondary forms. At present, immunodiagnosis is used too often in unambiguous cases of type 1 diabetes, but too rarely in supposed type 2 diabetes. As a rule, LADA patients are GADA-positive. If MODY diabetes is suspected, a genetic examination is indicated. In patients with GDM, antibody testing with GADA makes sense, in particular in slim patients receiving insulin treatment, since these patients have a high risk for developing a postpartum diabetes already in the first years.
 ...
PMID:[Diabetes mellitus--differential diagnosis]. 1680 91

People with obesity, especially extreme obesity, are at risk for many health problems. However, the responsible genes remain unknown in >95% of severe obesity cases. Our previous genome-wide scan of Wagyu x Limousin F2 cattle crosses with extreme phenotypes revealed a molecular marker significantly associated with intramuscular fat deposition. Characterization of this marker showed that it is orthologous to the human gene KIAA1462 located on HSA10p11.23, where a major quantitative trait locus for morbid obesity has been reported. The newly identified mitochondrial poly(A) polymerase associated domain containing 1 (PAPD1) gene, which is located near this marker, is particularly interesting because the polymerase is required for the polyadenylation and stabilization of mammalian mitochondrial mRNAs. In the present study, both cDNA and genomic DNA sequences were annotated for the bovine PAPD1 gene and ten genetic markers were detected in the promoter and exon 1 region. Among seven markers assayed on approximately 250 Wagyu x Limousin F2 animals, two single nucleotide polymorphisms (SNPs) in the promoter region were significantly associated with intramuscular fat (P<0.05). However, there was a significant interaction (P<0.05) between a third SNP, which causes an amino acid change in coding exon 1, and each of these two promoter SNPs on intramuscular fat deposition. In particular, the differences between double heterozygous animals at two polymorphic sites and the slim genotype animals exceeded 2.3 standard deviations for the trait in both cases. Our study provides evidence for a new mechanism--the involvement of compound heterosis in extreme obesity, which warrants further examination.
 ...
PMID:A novel nuclear-encoded mitochondrial poly(A) polymerase PAPD1 is a potential candidate gene for the extreme obesity related phenotypes in mammals. 1681 Mar 31


<< Previous 1 2 3 4 5 6 Next >>